# Cancer Therapy * **Definition:** A range of medical treatments and procedures designed to manage, control, or eliminate cancer, which may include surgery, chemotherapy, radiation therapy, immunotherapy, and targeted therapies, often tailored to the specific type and stage of cancer. * **Taxonomy:** Healthcare Topics / Cancer Therapy ## News * Selected news on the topic of **Cancer Therapy**, for healthcare technology leaders * 19.8K news items are in the system for this topic * Posts have been filtered for tech and healthcare-related keywords | Date | Title | Source | | --- | --- | --- | | 5/22/2025 | [**Deep Dive: Advanced Sarcoma and Other Tumor Applications with Methylation Profiling**](https://www.insideprecisionmedicine.com/multimedia/podcasts/sponsored-podcasts/deep-dive-advanced-sarcoma-and-other-tumor-applications-with-methylation-profiling/) | [[Inside Precision Medicine]] | | 5/14/2025 | [**FDA Fast-Tracks AbbVie's New Lung Cancer Therapy Emrelis For Tough Lung Cancer Cases**](https://www.aol.com/fda-fast-tracks-abbvies-lung-212505897.html) | [[AOL]] | | 5/13/2025 | [**Complement 1 Secures $16M for Clinically Validated Cancer Lifestyle Modification Platform**](https://hitconsultant.net/2025/05/13/complement-1-secures-16m-for-clinically-validated-cancer-lifestyle-modification-platform/) | [[HIT Consultant]] | | 3/31/2025 | [**AI-Driven Healthcare: The Future of Patient-Centric Care - by Ajay Singh - Medium**](https://medium.com/@ajay.singh_91430/ai-driven-healthcare-the-future-of-patient-centric-care-3292b0a49bfb) | [[Medium]] | | 3/8/2025 | [**The Weekly Round Up: March 8, 2025 - The Healthcare Technology Report.**](https://thehealthcaretechnologyreport.com/the-weekly-round-up-march-8-2025/) | [[Healthcare Technology Report]] | | 3/6/2025 | [**Helix Biopharma Corp. Expands Leadership Team - FirstWord Pharma**](https://firstwordpharma.com/story/5940414) | [[FirstWord PHARMA]] | | 2/18/2025 | [**Oncolytic Virus Cancer Therapy Pipeline Market Report: Competitive Analysis of Oncostar ...**](https://finance.yahoo.com/news/oncolytic-virus-cancer-therapy-pipeline-140600346.html) | [[Yahoo Finance]] | | 2/7/2025 | [**Modifying biomaterials may lead to more effective cancer therapies - News-Medical**](https://www.news-medical.net/news/20250207/Modifying-biomaterials-may-lead-to-more-effective-cancer-therapies.aspx) | [[News Medical Net]] | | 1/29/2025 | [**Targeting MYCN and MDM2 offers new hope for cancer therapy**](https://www.news-medical.net/news/20250129/Targeting-MYCN-and-MDM2-offers-new-hope-for-cancer-therapy.aspx) | [[News Medical Net]] | | 12/31/2024 | [**Precision Medicine Software Market Focused Insights 2024-2029, with Key Player Profiles of ...**](https://www.businesswire.com/news/home/20241231013633/en/Precision-Medicine-Software-Market-Focused-Insights-2024-2029-with-Key-Player-Profiles-of-Syapse-AccessDX-Laboratory-Fabric-Genomics-Foundation-Medicine-Intel-and-IBM---ResearchAndMarkets.com) | [[Business Wire]] | | 12/31/2024 | [**Precision Medicine Software Market Focused Insights 2024-2029, with Key Player Profiles of Syapse, AccessDX Laboratory, Fabric Genomics, Foundation Medicine, Intel and IBM - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20241231013633/en/Precision-Medicine-Software-Market-Focused-Insights-2024-2029-with-Key-Player-Profiles-of-Syapse-AccessDX-Laboratory-Fabric-Genomics-Foundation-Medicine-Intel-and-IBM---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-Q-tiwWZwkcswR1UZtV7eGe24xL9TZOyQUMS3J72mJlQ7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LOzmn6JePCpHPCiYGaEx4DL1Rq8pNwkf3AarimpDzQGuQ==) | [[Business Wire]] | | 12/31/2024 | [**Precision Medicine Software Market Focused Insights 2024-2029, with Key Player Profiles of Syapse, AccessDX Laboratory, Fabric Genomics, Foundation Medicine, Intel and IBM - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20241231013633/en/Precision-Medicine-Software-Market-Focused-Insights-2024-2029-with-Key-Player-Profiles-of-Syapse-AccessDX-Laboratory-Fabric-Genomics-Foundation-Medicine-Intel-and-IBM---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 12/3/2024 | [**Health IT Hires, Appointments, and Who's Hiring**](https://www.healthitanswers.net/health-it-hires-appointments-and-whos-hiring-120324/) | [[Health IT Answers]] | | 12/2/2024 | [**IDEAYA Biosciences Announces Participation in Upcoming December 2024 Investor Relations Events**](https://www.prnewswire.com/news-releases/ideaya-biosciences-announces-participation-in-upcoming-december-2024-investor-relations-events-302319106.html) | [[PR Newswire]] | | 11/29/2024 | [**Gamma Delta T Cell Cancer Therapy Market Competitive Landscape Analysis - LinkedIn**](https://www.linkedin.com/pulse/gamma-delta-cell-cancer-therapy-market-competitive-qy0we/) | [[Linkedin]] | | 11/28/2024 | [**Headlines Powered By Business Wire : AEROPRES( )**](https://www.businesswire.com/portal/site/aeropres/template.PAGE/menuitem.2ae9610138ef7fb9aeaeff10ad808a0c/?javax.portlet.tpst=7b2ed95b6e662fb9aeaeff10ad808a0c&javax.portlet.prp_7b2ed95b6e662fb9aeaeff10ad808a0c_viewID=MY_PORTAL_VIEW&javax.portlet.prp_7b2ed95b6e662fb9aeaeff10ad808a0c_ndmHsc=v2*A1730199600000*B1732816040921*DgroupByDate*G55*N1028704&javax.portlet.begCacheTok=com.vignette.cachetoken&javax.portlet.endCacheTok=com.vignette.cachetoken) | [[Business Wire]] | | 11/26/2024 | [**Lung Cancer Therapy Research Report 2023-2024 & 2029: $70.39 Billion Market Analysis By Treatment Method, Therapy Type, Indication, End-User and Region - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20241126191665/en/Lung-Cancer-Therapy-Research-Report-2023-2024-2029-70.39-Billion-Market-Analysis-By-Treatment-Method-Therapy-Type-Indication-End-User-and-Region---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 11/8/2024 | [**Malaysia Cancer Therapy and Testing Market By Application Size & Forecast - LinkedIn**](https://www.linkedin.com/pulse/malaysia-cancer-therapy-testing-market-application-tqtue) | [[Linkedin]] | | 11/4/2024 | [**Japan Prostate Cancer Therapy Market Valuation to Go Beyond US$ 2964.99 Million By 2032**](https://finance.yahoo.com/news/japan-prostate-cancer-therapy-market-123000958.html) | [[Yahoo Finance]] | | 10/11/2024 | [**Siloam Hospitals ramp up AI integrations and more partnership briefs - Healthcare IT News**](https://www.healthcareitnews.com/news/asia/siloam-hospitals-ramp-ai-integrations-and-more-partnership-briefs) | [[Healthcare IT News]] | | 8/26/2024 | [**CD Antigen Cancer Therapy Market 2024: Trends, Innovations, And Growth Outlook**](https://www.barchart.com/story/news/28220220/cd-antigen-cancer-therapy-market-2024-trends-innovations-and-growth-outlook) | barchart.com | | 7/26/2024 | [**Smart Medicine: The Role of AI in Modern Healthcare - GIS user technology news**](https://gisuser.com/2024/07/smart-medicine-the-role-of-ai-in-modern-healthcare/) | gisuser.com | | 7/23/2024 | [**Personalized Healthcare Revolution: Advantages of Precision Medicine**](https://www.healthcaretechoutlook.com/news/personalized-healthcare-revolution-advantages-of-precision-medicine-nid-4209.html) | healthcaretechoutlook.com | | 7/17/2024 | [**Harvard Business School Announces Its 2024-2025 Blavatnik Fellows - News**](https://www.hbs.edu/news/releases/Pages/2024-2025-blavatnik-fellows.aspx) | hbs.edu | | 7/10/2024 | [**Milwaukee-based experts available during RNC - News - MSOE**](https://www.msoe.edu/about-msoe/news/details/milwaukee-based-experts-available-during-rnc) | msoe.edu | ## Topic Overview (Some LLM-derived content — please confirm with above primary sources) ### Key Players - **Hoth Therapeutics**: A company developing treatments to address dermatological effects faced by cancer patients receiving EGFR inhibitors. - **Cancer Research Horizons**: Another notable investor in Trogenix, supporting advancements in cancer treatment. - **Mayo Clinic**: A leading healthcare institution collaborating with technology startups to enhance cancer diagnostics. - **Debra Patt, MD, PhD**: An advocate for value-based care in oncology, emphasizing the importance of effective strategies in cancer therapy. - **Merck**: A pharmaceutical company known for its leading cancer therapy, Keytruda, which utilizes the immune system to combat cancer. - **Diakonos Oncology**: A company focused on developing innovative cancer immunotherapies, including a dendritic cell vaccine for glioblastoma. - **Perthera**: A leader in precision oncology decision support, utilizing AI to provide personalized therapy options. - **Dr. Ken Macnamara**: CEO of Trogenix, focusing on innovative cancer treatment technologies. - **Azra AI**: Focuses on AI-powered oncology workflow automation to improve cancer diagnosis and patient routing. - **BPGbio**: A company focused on developing therapies for aggressive cancer phenotypes using AI and innovative approaches. - **Gilead Sciences**: A biopharmaceutical company known for its cancer therapy Trodelvy, which targets the TROP-2 protein. - **Trogenix Ltd**: A company commercializing a Synthetic Super-Enhancer platform aimed at targeting aggressive cancers. - **Foundation Medicine**: Offers genomic profiling services to help match patients with targeted therapies. - **Cosmos Health**: A diversified healthcare group focusing on innovative oncology therapeutics and R&D partnerships. - **ConcertAI**: A healthcare technology company that collaborates with Guardant Health to create a Data-as-a-Service platform for cancer therapy research. - **Dr. Mohsen Farsad**: Reported positive outcomes with Rhenium-SCT for non-melanoma skin cancer treatment. - **Guardant Health**: A company specializing in blood tests for cancer detection and monitoring, aiming to transform cancer patient care. - **IQ Capital**: An investor in Trogenix, contributing to the funding of innovative cancer therapies. - **WhiteLab Genomics**: A partner of Debiopharm utilizing AI to enhance drug delivery targeting in cancer therapies. ### Partnerships and Collaborations - **Vivan Therapeutics**: Employs AI to create personalized cancer treatments, matching patients' tumor profiles to tailored therapies. - **OncoBeta and Bolzano Hospital**: Expanded Rhenium-SCT treatment services for non-melanoma skin cancer in Italy. - **Guardant Health and ConcertAI**: Collaborating to create a Data-as-a-Service platform integrating clinical and tumor profiling data to enhance cancer therapy research. - **Mayo Clinic and JelloX Biotech**: Collaborating to enhance AI-powered imaging analysis technology for cancer diagnoses. - **AOP Orphan Pharmaceuticals and Leukos Biotech**: Initiated the SERONCO-1 clinical trial for a drug targeting solid tumors and lymphomas. - **Sanofi and Exscientia**: Partnership to utilize AI in developing new cancer treatments. - **University of North Carolina-Chapel Hill and ARPA-H**: Establishing the Cancer Identification and Precision Oncology Center to enhance cancer diagnosis using AI. - **Debiopharm and WhiteLab Genomics**: Strategic partnership to utilize AI for identifying cancer-specific receptors and enhancing drug delivery. - **InfuSystem and Sanara MedTech**: Exclusive distribution agreement for ChemoMouthpiece, an oral cryotherapy device for cancer patients. - **Gilead Sciences and Tubulis**: An exclusive agreement to develop antibody-drug conjugates targeting solid tumors. - **Trogenix and 4BIO Capital**: Collaboration to develop the Odysseus platform for precision cancer treatment. - **Yuhan Corporation and KAIST**: Collaborating on AI-driven research to develop personalized lung cancer therapies. - **SHINE Technologies and Oncidium Foundation**: Partnering to enhance global access to radiopharmaceutical therapy, providing doses to under-resourced countries. - **IMU Biosciences and the MANIFEST consortium**: Collaboration to study immunotherapy responses and side effects in cancer patients. - **J INTS BIO and Yonsei University**: Launching an AI-driven collaboration for precision oncology aimed at revolutionizing cancer treatment. - **Merck and Pfizer**: Major pharmaceutical companies collaborating on RNA-based inhibitors and targeting infectious diseases, respectively, to enhance oncology therapies. - **Insilico Medicine and Fosun Pharma**: Collaboration to deliver preclinical candidate compounds targeting solid tumors. - **Humana and Thyme Care**: Initiated a value-based agreement to enhance cancer care support for Medicare Advantage members. - **Guardant Health and MiBA**: A partnership aimed at enhancing precision medicine through improved biomarker testing and data analytics in cancer care. - **Carta Healthcare and Realyze Intelligence**: Acquisition to improve AI-driven software for clinical trial matching and patient outcomes. ### Innovations, Trends, and Initiatives - **Trojan-horse therapy**: Developed by Yale Cancer Center, allowing tumor-fighting antibodies to infiltrate tumors effectively. - **Tetraspecific Antibody Therapies**: Emerging therapies expected to significantly impact cancer treatment by targeting multiple cancer markers. - **Oncolytic Virus Cancer Therapy**: Utilizes genetically modified viruses to selectively infect and destroy cancer cells, with recent FDA approvals highlighting its potential. - **Natural Extracts in Cancer Therapy**: Research on compounds like oleanic acid shows potential for enhancing chemotherapy effectiveness and reducing side effects. - **AI in Cancer Therapy**: AI is enhancing diagnostics, treatment personalization, and operational efficiency in cancer care. - **Intratumoral Delivery Methods**: Emerging techniques gaining traction in precision medicine and immunotherapy for cancer treatment. - **mRNA Technology in Cancer Treatment**: Advancements in mRNA vaccines are being explored for personalized cancer therapies. - **Ketogenic Diet and Cancer Therapy**: Research from UC San Francisco shows a ketogenic diet combined with eFT508 can eliminate pancreatic cancer in mice. - **mRNA Technology**: Potential to revolutionize cancer treatment by engaging the immune system for anti-tumor responses. - **Liquid Biopsy Technology**: Revolutionizing cancer treatment by providing real-time insights into cancer progression. - **Gold Nanoparticles for Cancer Treatment**: Developed by researchers to enhance treatment precision by delivering therapeutic nucleic acids and heating tumor cells effectively. - **Cure51**: Aims to leverage exceptional cancer survival cases to uncover effective treatments through data analysis. - **Alpha DaRT**: An innovative alpha-radiation therapy for solid tumors, minimizing damage to surrounding healthy tissue. - **AI-driven Diagnostic Tools**: Innovations in healthcare technology aimed at improving cancer diagnosis and treatment outcomes. - **CAR T-cell Therapy**: Significant growth in the CAR T-cell therapy market, with recent FDA approvals for new therapies. - **Precision Medicine**: Tailoring treatments to individual patient characteristics, enhancing the precision of cancer therapies. - **AI in Cancer Diagnostics**: Emerging technologies like AI and machine learning are transforming cancer therapy by enabling early disease classification and personalized treatment pathways. - **Neoantigen vaccines**: Targeting unique mutations in cancer cells, utilizing AI and genomic sequencing for personalized therapies. - **Bio-laser Technology for CTC Detection**: A new method developed to improve the detection and analysis of circulating tumor cells, crucial for effective treatment outcomes. ### Challenges and Concerns - **Drug Delivery Efficacy**: Traditional cancer treatments face challenges with non-specific drug distribution and toxicity to healthy cells. - **Complexity of Cancer**: The adaptability of cancer cells poses ongoing challenges for effective treatment strategies. - **Cardiovascular Toxicity**: The growing concern of cardiovascular side effects from cancer treatments, necessitating effective management strategies. - **Regulatory Oversight**: The need for enhanced regulations to manage risks associated with new cancer therapies and ensure patient safety. - **High Treatment Costs**: A significant barrier to accessing innovative cancer therapies, particularly in regenerative medicine. - **Ethical Issues**: Concerns surrounding stem cell research and its implications for cancer treatment. - **Regulatory Hurdles**: Challenges in navigating regulatory frameworks can slow the adoption of innovative cancer therapies. - **Cost and Toxicity of Treatments**: Challenges such as high costs and systemic toxicity are associated with CAR T-cell therapies. - **Access to Care**: Concerns over the availability of in-person palliative care for cancer patients, with studies showing video visits can be effective. - **Obesity Paradox**: Research indicates varying effectiveness of immunotherapy and chemotherapy based on BMI, complicating treatment decisions. - **Legal Disputes**: AbbVie and BeiGene's lawsuit highlights concerns over trade secrets in cancer therapy development. - **Trodelvy's Clinical Trial Failures**: Concerns raised about the drug's accelerated approval status following disappointing trial outcomes. - **Incorporating Patient Feedback**: The need for better integration of patient quality of life feedback in clinical trials, which has historically been overlooked. - **Diversity in Clinical Trials**: The FDA's new guidance aims to improve diversity in clinical trials, highlighting the need for better representation. - **Cybersecurity Concerns**: As healthcare technology evolves, ensuring the security of patient data becomes increasingly important. - **Drug Pricing Negotiations**: Concerns in the pharmaceutical industry regarding government price negotiations that may hinder innovation in drug development. - **Data Interoperability Issues**: Lack of standardization in data sharing can hinder the effectiveness of precision medicine initiatives. - **Patient Privacy**: Ensuring patient privacy and informed consent while promoting responsible data sharing is a critical concern in genetic testing. ## Related Topics [[Cancer Treatment]]; [[Cancer Immunotherapy]]; [[Cancer Diagnostics]]; [[Cell Therapy]]